|
({1-[2-(2-fluorophenyl)ethyl]-4-piperidinyl}methyl)methyl(3-thienylmethyl)amine |
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Compound 7b (internal name in literature) |
Depiction based on curated SMILES
N
Cl
Cl
CH
3
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Compound 7d (internal name in literature) |
Depiction based on curated SMILES
N
Br
Br
CH
3
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Compound 8j (internal name in literature) |
Depiction based on curated SMILES
CH
3
N
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
N-benzyl-N-(2-phenylethyl)-1-propyl-4-piperidinamine |
Depiction based on curated SMILES
CH
3
N
N
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
(5-BROMO-2-METHOXYBENZYL)[2-(3-FLUOROPHENYL)ETHYL]AMINE |
Depiction based on curated SMILES
N
H
F
CH
3
Br
O
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
4-(2-(Pyrrolidin-1-yl)ethyl)aniline |
Depiction based on curated SMILES
H
2
N
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dey S, et al. 2017. ChemMedChem |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |